Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials - Concepedia

Concepedia

Publication | Closed Access

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

1.2K

Citations

23

References

2015

Year

Mario Castro, James Zangrilli, Michael E. Wechsler, Eric D. Bateman, Guy Brusselle, Philip G. Bardin, Kevin Murphy, Jorge Máspero, Christopher O’Brien, Stephanie Korn

The Lancet Respiratory Medicine

AsthmaAllergyAllergy MedicineClinical TrialsEosinophilic DisorderMedicinePulmonary Disease

References

	Year	Citations

Page 1